• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2025, Vol. 27 ›› Issue (2): 169-174.DOI: 10.3969/j.issn.1671-2587.2025.02.004

• 临床输血 • 上一篇    下一篇

一例意外抗体阳性患者造血干细胞移植后抗体监测结果分析

付丽辉1, 马春娅1, 罗圆圆1, 沈伟2, 向东2, 于洋1   

  1. 1解放军总医院第一医学中心输血医学科,北京 100853;
    2上海市血液中心,上海 200051
  • 收稿日期:2024-12-04 出版日期:2025-04-20 发布日期:2025-04-17
  • 通讯作者: 于洋,主要从事临床输血学研究,(E-mail)yuy301@163.com。
  • 作者简介:付丽辉,主要从事血型参比相关研究,(E-mail)guaihuier3@163.com。

Analysis of Antibody Monitoring Results after Hematopoietic Stem Cell Transplantation in a Patient with Unexpected Antibody Positivity

FU Lihui1, MA Chunya1, LUO Yuanyuan1, SHEN Wei2, XIANG Dong2, YU Yang1   

  1. 1Department of Transfusion Medicine, The First Medical Center of PLA General Hospital, Beijing 100853;
    2Shanghai Blood Center, Shanghai 200051
  • Received:2024-12-04 Online:2025-04-20 Published:2025-04-17

摘要: 目的 研究抗-E意外抗体阳性患者在脐带血造血干细胞移植E阳性抗原后血清学变化特点、实验室检测方法及输血策略。方法 采用血清学常规方法进行ABO、Rh血型鉴定及意外抗体筛查试验,使用PEG增强技术及酸放散试验进行意外抗体鉴定;应用流式细胞术进行细胞分群检测,分析血型抗原转换及抗体转归规律。结果 患者移植前血型为AB型,Rh分型为CCDee,存在抗-E意外抗体。非亲缘脐带血造血干细胞供者为B型,Rh分型为ccDEE,亲缘半相合外周血造血干细胞供者为AB型,Rh分型为CcDEe。患者处于血型转型期,意外抗体筛查结果为阴性,但通过PEG增强试验及红细胞酸放散试验均检出IgG抗-E抗体。结论 对于移植前存在同种抗体的患者,在移植转型期,建议采用PEG增强抗人球蛋白试验等手段作为常规血清学检测的补充,监测同种抗体水平的变化,预防溶血反应,避免红细胞输注无效。

关键词: 抗-E抗体, 非亲缘脐带血造血干细胞移植, Rh血型转型, 流式细胞术

Abstract: Objective To study the serological changes, laboratory detection methods, and transfusion strategies for patients with positive anti-E unexpected antibodies after umbilical cord blood hematopoietic stem cell transplantation with E-positive antigens. Methods ABO and Rh blood typing and unexpected antibody screening tests were performed using conventional serological methods. Unexpected antibody identification was conducted using PEG enhancement technology and acid elution test. Cell population detection was carried out using flow cytometry to analyze the patterns of blood group antigen conversion and antibody resolution. Results The patient had pretransplant blood type AB, Rh type CCDee, with anti-E unexpected antibodies. Unrelated cord blood HSC donor was type B, Rh classification was ccDEE, related hemicompatible peripheral blood HSC donor was type AB, and Rh classification was CcDEe. The patient was in blood group transition and the unexpected antibody screening result was negative, but IgG anti-E antibody was detected by PEG enhancement test and erythrocyte acid release test. Conclusion For patients with similar antibodies before transplantation, PEG enhanced anti-human globulin test is recommended as a supplement to routine serological tests, monitor the changes of alloantibody levels, prevent hemolytic reaction and avoid red cell transfusion refractoriness.

Key words: Anti-E antibody, Unrelated Umbilical Cord Blood Hematopoietic Stem Cell Transplantation, Rh blood group transformation, Flow cytometry

中图分类号: